LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 36.01 | 27.76 | 878 | 2662 | 0.3297 | 0.6898 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.71 | 27.76 | 61 | 2877 | 0.0212 | 0.1248 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.71 | 27.76 | 641 | 2877 | 0.2228 | 0.5982 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.71 | 27.76 | 28 | 2877 | 0.0097 | 0.0013 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 37.71 | 27.76 | 882 | 2877 | 0.3065 | 0.6762 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.41 | 27.76 | 70 | 3105 | 0.0225 | 0.1456 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.41 | 27.76 | 638 | 3105 | 0.2054 | 0.5850 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.41 | 27.76 | 27 | 3105 | 0.0087 | -0.0041 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 39.41 | 27.76 | 876 | 3105 | 0.2821 | 0.6606 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.11 | 27.76 | 66 | 3331 | 0.0198 | 0.1336 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.11 | 27.76 | 647 | 3331 | 0.1942 | 0.5776 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.11 | 27.76 | 26 | 3331 | 0.0078 | -0.0094 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 41.11 | 27.76 | 877 | 3331 | 0.2632 | 0.6486 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 42.81 | 27.76 | 73 | 3596 | 0.0203 | 0.1477 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 42.81 | 27.76 | 646 | 3596 | 0.1796 | 0.5660 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 42.81 | 27.76 | 23 | 3596 | 0.0064 | -0.0264 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 42.81 | 27.76 | 852 | 3596 | 0.2369 | 0.6290 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.52 | 27.76 | 72 | 3884 | 0.0185 | 0.1431 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.52 | 27.76 | 645 | 3884 | 0.1661 | 0.5547 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.52 | 27.76 | 23 | 3884 | 0.0059 | -0.0260 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.52 | 27.76 | 851 | 3884 | 0.2191 | 0.6163 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.22 | 27.76 | 82 | 4125 | 0.0199 | 0.1620 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.22 | 27.76 | 639 | 4125 | 0.1549 | 0.5445 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.22 | 27.76 | 21 | 4125 | 0.0051 | -0.0379 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.22 | 27.76 | 851 | 4125 | 0.2063 | 0.6070 | MN20160318_Q01 | K20 |